Last reviewed · How we verify
Somatropin Injection low dose group — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Somatropin Injection low dose group (Somatropin Injection low dose group) — Changchun GeneScience Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Somatropin Injection low dose group TARGET | Somatropin Injection low dose group | Changchun GeneScience Pharmaceutical Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Somatropin Injection low dose group CI watch — RSS
- Somatropin Injection low dose group CI watch — Atom
- Somatropin Injection low dose group CI watch — JSON
- Somatropin Injection low dose group alone — RSS
Cite this brief
Drug Landscape (2026). Somatropin Injection low dose group — Competitive Intelligence Brief. https://druglandscape.com/ci/somatropin-injection-low-dose-group. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab